Journal Logo

Most Popular Articles

Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up

Dimopoulos, Meletios A.; Moreau, Philippe; Terpos, Evangelos; More

HemaSphere. 5(2):e528, February 2021.

Outcome of COVID-19 in Patients With Mantle Cell Lymphoma—Report From the European MCL Registry

Tilch, Marie-Kristin; Visco, Carlo; Kinda, Sandra; More

HemaSphere. 6(5):e0711, May 2022.

Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal

Valent, Peter; Akin, Cem; Hartmann, Karin; More

HemaSphere. 5(11):e646, November 2021.

Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working Party

Tettero, Jesse M.; Freeman, Sylvie; Buecklein, Veit; More

HemaSphere. 6(1):e676, January 2022.

Monitoring of Leukemia Clones in B-cell Acute Lymphoblastic Leukemia at Diagnosis and During Treatment by Single-cell DNA Amplicon Sequencing

Meyers, Sarah; Alberti-Servera, Llucia; Gielen, Olga; More

HemaSphere. 6(4):e700, April 2022.

Cytogenetics in Chronic Lymphocytic Leukemia: ERIC Perspectives and Recommendations

Baliakas, Panagiotis; Espinet, Blanca; Mellink, Clemens; More

HemaSphere. 6(4):e707, April 2022.

Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults: Recommendations From the European Hematology Association and the European LeukemiaNet

Itzykson, Raphael; Fenaux, Pierre; Bowen, David; More

HemaSphere. 2(6):e150, December 2018.

Inflammatory Cytokine Profiles Do Not Differ Between Patients With Idiopathic Cytopenias of Undetermined Significance and Myelodysplastic Syndromes

Nielsen, Amalie Bach; Hansen, Jakob Werner; Ørskov, Andreas Due; More

HemaSphere. 6(5):e0713, May 2022.

Prognostic Stratification of Diffuse Large B-cell Lymphoma Using Clinico-genomic Models: Validation and Improvement of the LymForest-25 Model

Mosquera Orgueira, Adrián; Díaz Arías, Jose Ángel; Cid López, Miguel; More

HemaSphere. 6(4):e706, April 2022.

Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future

Heine, Renaud; Thielen, Frederick W.; Koopmanschap, Marc; More

HemaSphere. 5(2):e524, February 2021.

Diagnosis and Treatment of Chronic Lymphocytic Leukemia: Recommendations of the French CLL Study Group (FILO)

Quinquenel, Anne; Aurran-Schleinitz, Thérèse; Clavert, Aline; More

HemaSphere. 4(5):e473, October 2020.

COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma

Gaitzsch, Erik; Passerini, Verena; Khatamzas, Elham; More

HemaSphere. 5(7):e603, July 2021.

Immunochemotherapy and Maintenance With Obinutuzumab or Rituximab in Patients With Previously Untreated Marginal Zone Lymphoma in the Randomized GALLIUM Trial

Herold, Michael; Hoster, Eva; Janssens, Ann; More

HemaSphere. 6(3):e699, March 2022.

Risk Factors and Mortality of COVID-19 in Patients With Lymphoma: A Multicenter Study

Regalado-Artamendi, Isabel; Jiménez-Ubieto, Ana; Hernández-Rivas, José Ángel; More

HemaSphere. 5(3):e538, March 2021.

P05: DARATUMUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE VERSUS LENALIDOMIDE AND DEXAMETHASONE ALONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: OVERALL SURVIVAL RESULTS FROM THE PHASE 3 POLLUX TRIAL

Dimopoulos, MA; Oriol, A; Nahi, H; More

HemaSphere. 6:13, April 2022.

Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report

Rodeghiero, Francesco; Pabinger, Ingrid; Ragni, Margaret; More

HemaSphere. 3(5):e286, October 2019.

Precision Medicine in Hematology 2021: Definitions, Tools, Perspectives, and Open Questions

Valent, Peter; Orfao, Alberto; Kubicek, Stefan; More

HemaSphere. 5(3):e536, March 2021.

P04: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE VERSUS BORTEZOMIB AND DEXAMETHASONE ALONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: OVERALL SURVIVAL RESULTS FROM THE PHASE 3 CASTOR TRIAL

Sonneveld, P; Chanan-Khan, A; Weisel, K; More

HemaSphere. 6:12, April 2022.

Next-generation Sequencing in Bone Marrow Failure Syndromes and Isolated Cytopenias: Experience of the Spanish Network on Bone Marrow Failure Syndromes

Gálvez, Eva; Vallespín, Elena; Arias-Salgado, Elena G.; More

HemaSphere. 5(4):e539, April 2021.

P06: UPDATED RESULTS FROM THE PHASE 1/2 MAJESTEC-1 STUDY OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

Popat, R; Usmani, S; Garfall, A; More

HemaSphere. 6:14, April 2022.

COVID-19 – Impact on Childhood Haematology Patients

Wolfs, Tom F.W.; Attarbaschi, Andishe; Balduzzi, Adriana; More

HemaSphere. 4(5):e465, October 2020.

Safety and Efficacy: Clinical Experience of Venetoclax in Combination With Hypomethylating Agents in Both Newly Diagnosed and Relapsed/Refractory Advanced Myeloid Malignancies

Feld, Jonathan; Tremblay, Douglas; Dougherty, Mikaela; More

HemaSphere. 5(4):e549, April 2021.

The EHA Research Roadmap: Transfusion Medicine

Stanworth, Simon J.; Brand, Anneke; Kaveri, Srini V.; More

HemaSphere. 6(2):e670, February 2022.

Recommendations for Pregnancy in Rare Inherited Anemias

Taher, Ali T.; Iolascon, Achille; Matar, Charbel F.; More

HemaSphere. 4(4):e446, August 2020.

The European Medicines Agency Review of Tafasitamab in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Delgado, Julio; Papadouli, Irene; Sarac, Sinan B.; More

HemaSphere. 5(12):e666, December 2021.

Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults: Recommendations for Genetic Diagnosis, Clinical Management and Follow-up

Baliakas, Panagiotis; Tesi, Bianca; Wartiovaara-Kautto, Ulla; More

HemaSphere. 3(6):e321, December 2019.

Management and Outcomes of Diffuse Large B-cell Lymphoma Post-transplant Lymphoproliferative Disorder in the Era of PET and Rituximab: A Multicenter Study From the Australasian Lymphoma Alliance

Boyle, Stephen; Tobin, Joshua W. D.; Perram, Jacinta; More

HemaSphere. 5(11):e648, November 2021.

Pomalidomide in Patients With Relapsed and/or Refractory Multiple Myeloma: A Prospective Study Within the Nationwide Netherlands Cancer Registry

Wester, Ruth; Dinmohamed, Avinash G.; van der Holt, Bronno; More

HemaSphere. 6(2):e683, February 2022.

P22: A NON-INTERVENTIONAL, PROSPECTIVE, OBSERVATIONAL STUDY OF RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED WITH IXAZOMIB IN REAL-WORLD SETTINGS IN GREECE; INTERIM RESULTS OF THE ‘OL-ORAL’ STUDY

Katodritou, E; Kyrtsonis, MC; Delimpasi, S; More

HemaSphere. 6:23, April 2022.

External Validation of the Revised Pretransplant Assessment of Mortality Score in Allogeneic Hematopoietic Cell Transplantation: A Cohort Study

Fattinger, Nicolas; Roth, Jan A.; Baldomero, Helen; More

HemaSphere. 6(4):e704, April 2022.

Show: